Biotech CBC Group Completes Strategic Acquisition of UCB’s Mature Product Portfolio in China November 30, 2024
Biotech Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline November 29, 2024
Biotech Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight November 29, 2024
Biotech Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference November 29, 2024
Biotech Myotonic Dystrophy Clinical Trial Pipeline Boom as Over 20 Companies Leading the Charge in Research and Development | DelveInsight November 28, 2024
Biotech Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China’s National Reimbursement Drug List November 28, 2024
Biotech New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List November 28, 2024
Biotech Kelun-Biotech’s TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC November 27, 2024
Biotech Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment for Cognitive Impairment Associated with Schizophrenia November 26, 2024
Biotech J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment ‘JIN-001’ – Enhancing Radiation and Chemotherapy Efficacy November 25, 2024
Search
Biotech
November 30, 2024
November 29, 2024
November 29, 2024
November 29, 2024
November 28, 2024
November 28, 2024
November 28, 2024
November 27, 2024
November 26, 2024
November 25, 2024
